BVES regulates c-Myc stability via PP2A and suppresses colitis-induced tumourigenesis.(blood vessel epicardial substance )
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2017 |
|---|---|
| Erschienen: |
2017 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:66 |
|---|---|
| Enthalten in: |
Gut - 66(2017), 5 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Chen, Xi [VerfasserIn] |
|---|
| Themen: |
Cellular proteins |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
OLC1994544732 |
|---|
| LEADER | 01000caa a2200265 4500 | ||
|---|---|---|---|
| 001 | OLC1994544732 | ||
| 003 | DE-627 | ||
| 005 | 20230715054040.0 | ||
| 007 | tu | ||
| 008 | 170721s2017 xx ||||| 00| ||eng c | ||
| 028 | 5 | 2 | |a PQ20170901 |
| 035 | |a (DE-627)OLC1994544732 | ||
| 035 | |a (DE-599)GBVOLC1994544732 | ||
| 035 | |a (PRQ)g1722-6216e8310ec01f69e4c131c1ce85792a9e265f50c4e6840090fc196e88a61ed00 | ||
| 035 | |a (KEY)0064913920170000066000500000bvesregulatescmycstabilityviapp2aandsuppressescoli | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q DNB |
| 100 | 1 | |a Chen, Xi |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a BVES regulates c-Myc stability via PP2A and suppresses colitis-induced tumourigenesis.(blood vessel epicardial substance ) |
| 264 | 1 | |c 2017 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 650 | 4 | |a Complications and side effects | |
| 650 | 4 | |a Colon cancer | |
| 650 | 4 | |a Research | |
| 650 | 4 | |a Inflammatory bowel diseases | |
| 650 | 4 | |a Cellular proteins | |
| 700 | 1 | |a Washington, Mary K |4 oth | |
| 700 | 1 | |a Kaz, Andrew M |4 oth | |
| 700 | 1 | |a Mittal, Mukul K |4 oth | |
| 700 | 1 | |a Grady, William M |4 oth | |
| 700 | 1 | |a Brand, Thomas |4 oth | |
| 700 | 1 | |a Bader, David M |4 oth | |
| 700 | 1 | |a Brentnall, Teresa A |4 oth | |
| 700 | 1 | |a Smith, J Joshua |4 oth | |
| 700 | 1 | |a Parang, Bobak |4 oth | |
| 700 | 1 | |a Barrett, Caitlyn W |4 oth | |
| 700 | 1 | |a Wilson, Keith T |4 oth | |
| 700 | 1 | |a Tansey, William P |4 oth | |
| 700 | 1 | |a Williams, Christopher S |4 oth | |
| 700 | 1 | |a Keating, Cody E |4 oth | |
| 700 | 1 | |a Chen, Ru |4 oth | |
| 700 | 1 | |a Revetta, Frank L |4 oth | |
| 700 | 1 | |a Naik, Rishi D |4 oth | |
| 700 | 1 | |a Ning, Wei |4 oth | |
| 700 | 1 | |a Short, Sarah P |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Gut |d London : BMJ Publishing Group, 1960 |g 66(2017), 5 |w (DE-627)129269301 |w (DE-600)80128-8 |w (DE-576)014459752 |x 0017-5749 |7 nnns |
| 773 | 1 | 8 | |g volume:66 |g year:2017 |g number:5 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4126 | ||
| 912 | |a GBV_ILN_4219 | ||
| 951 | |a AR | ||
| 952 | |d 66 |j 2017 |e 5 | ||